Swiss medicine producer Roche Holding AG announced on November 8 that the company had stopped selling its anti-virus medicine "Tamiflu" in China, and had passed on those in stock to the Chinese government, International Finance News reported.

Tamiflu is widely believed one of the few medicines effective in the prevention of bird flu.

According to the company's Shanghai office, Tamiflu supplied by Roche is being transported to China's Ministry of Health for centralized distribution.

By People's Daily Online